EGF and cancer: Thus, our findings have not only revealed previously unknown significance of EGF-stimulated release of SHCBP1 but more importantly also uncovered a new mode of crosstalk between the EGFR and β-catenin pathways and a novel mechanism involved in EGFR regulation of cancer cell stemness.